Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Lung Neoplasms 1 Leukemia 1 Glioblastoma 1 Disease 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Gastric Cancer 1

Interventions

Etoposide 10 Cisplatin 9 Cyclophosphamide 7 etoposide phosphate 5 Paclitaxel 5 Ifosfamide 5 Granulocyte Colony-Stimulating Factor 5 Carboplatin 5 fludarabine 4 Sirolimus 4 Gemcitabine 4 pembrolizumab 3 fludarabine phosphate 3 Sunitinib 3 Mesna 3 Melphalan 3 Filgrastim 3 Drug Therapy 3 Brentuximab Vedotin 3 Bleomycin 3 Bevacizumab 3 Automobiles 3 tremelimumab 2 sodium thiosulfate 2 pegfilgrastim 2 lutetium Lu 177 dotatate 2 durvalumab 2 Vorinostat 2 Stem Cell Transplantation 2 Oxaliplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms, Germ Cell and Embryonal × Drug Therapy, Combination × Clear all

NCT01782339 2024-06-14

GAMMA

Barts & The London NHS Trust

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡